Barbara Siebertz, Dr. rer. nat. graduated at the Albertus-Magnus-University of Cologne with a diploma degree in Biology in 1986. She received her PHD and worked at the Max-Planck-Institute for Plant Breeding Research in Cologne up to 1992. The topic of her thesis was the elucidation of a molecular regulatory mechanism in wounded plants.
Up to 1995 she joined Sandoz Pharma in Basel in the Department of Immunology, followed by an additional time of research at the Rheinisch-Westfälische Technische Hochschule in Aachen in the department of Pathological Biochemistry. In 1998 she joined Biofrontera Pharmaceuticals GmbH and started her activities in Regulatory Affairs activities. From 2013-2015 she was engaged in Regulatory Affairs studies at the University of Bonn and joined Sträter Life Science GmbH in 2015. With the beginning of 2018 she joined Pharmalex and helds the position as Senior Manager in Regulatory Affairs and Special Projects.
